Heron Therapeutics (HRTX) ROE US GAAP (year values)

2019 2020 2021 2022 2023   LTM ?
ROE, % ? -50.7% -94.9% -280.6% -991.1% 325.4%   126.9%
Changes by years, y/y, % -2pp -44pp -186pp -711pp +1 317pp    

Heron Therapeutics. ROE, %

Heron Therapeutics. ROE, changes, pp

Heron Therapeutics (HRTX) ROE US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2024Q1 2024Q2   LTM ?
ROE, % ? 365.7% 456.2% 324.6% 239.7% 126.9%   126.9%
Changes by years, y/y, % -705pp +1 446pp +1 778pp -1 203pp -239pp    
Changes by quarters, q/q, % -1 077pp +90pp -132pp -85pp -113pp    

Heron Therapeutics. ROE, %

Heron Therapeutics. ROE, changes, pp

Heron Therapeutics. ROE, changes, pp